Procter & Gamble Company (The) $PG Shares Sold by Welch & Forbes LLC

Welch & Forbes LLC decreased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 0.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 750,174 shares of the company’s stock after selling 4,451 shares during the quarter. Procter & Gamble comprises approximately 1.3% of Welch & Forbes LLC’s investment portfolio, making the stock its 22nd biggest holding. Welch & Forbes LLC’s holdings in Procter & Gamble were worth $108,985,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Pinion Investment Advisors LLC raised its stake in shares of Procter & Gamble by 3.1% during the third quarter. Pinion Investment Advisors LLC now owns 7,612 shares of the company’s stock worth $1,106,000 after buying an additional 230 shares during the last quarter. Altiora Financial Group LLC boosted its stake in Procter & Gamble by 40.5% in the third quarter. Altiora Financial Group LLC now owns 3,601 shares of the company’s stock valued at $523,000 after acquiring an additional 1,038 shares during the last quarter. M&G PLC boosted its stake in Procter & Gamble by 7.9% in the third quarter. M&G PLC now owns 16,408 shares of the company’s stock valued at $2,379,000 after acquiring an additional 1,204 shares during the last quarter. Vestor Capital LLC grew its holdings in Procter & Gamble by 455.0% during the 3rd quarter. Vestor Capital LLC now owns 10,506 shares of the company’s stock worth $1,526,000 after acquiring an additional 8,613 shares during the period. Finally, Clear Wave Wealth Management LLC grew its holdings in Procter & Gamble by 19.2% during the 3rd quarter. Clear Wave Wealth Management LLC now owns 4,348 shares of the company’s stock worth $632,000 after acquiring an additional 699 shares during the period. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $168.17 on Tuesday. The company has a market capitalization of $389.77 billion, a PE ratio of 25.33, a PEG ratio of 4.11 and a beta of 0.36. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $170.52. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. The stock’s fifty day simple moving average is $152.49 and its 200 day simple moving average is $149.55.

Procter & Gamble (NYSE:PG) last posted its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. During the same period in the previous year, the firm earned $1.99 earnings per share. The company’s revenue was up 4.0% on a year-over-year basis. On average, research analysts predict that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.6%. Procter & Gamble’s payout ratio is presently 65.51%.

Wall Street Analysts Forecast Growth

Several analysts have commented on PG shares. Morgan Stanley upped their target price on shares of Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a research report on Friday, October 23rd. UBS Group set a $166.00 price target on Procter & Gamble in a research report on Friday, October 23rd. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $161.00 price objective on shares of Procter & Gamble in a research note on Thursday, October 22nd. BNP Paribas Exane upped their price objective on Procter & Gamble from $177.00 to $189.00 and gave the company an “outperform” rating in a report on Friday, October 23rd. Finally, Piper Sandler upped their price objective on Procter & Gamble from $145.00 to $167.00 and gave the company a “neutral” rating in a report on Monday, October 26th. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $170.57.

Insider Transactions at Procter & Gamble

In related news, CEO Sundar G. Raman sold 38,253 shares of the company’s stock in a transaction on Friday, October 30th. The shares were sold at an average price of $165.00, for a total value of $6,311,745.00. Following the completion of the transaction, the chief executive officer directly owned 47,745 shares of the company’s stock, valued at approximately $7,877,925. This represents a 44.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Shailesh Jejurikar sold 35,000 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the transaction, the chief executive officer directly owned 55,391 shares of the company’s stock, valued at approximately $9,033,718.19. The trade was a 38.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 197,756 shares of company stock valued at $32,336,001. 0.23% of the stock is currently owned by insiders.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: PG’s Beauty business delivered 5% organic sales growth in fiscal Q1 2027, supported by Pantene and SK-II, as innovation and stronger brand execution helped demand. Continued momentum could support company growth, though the article questions whether it will be enough to lift results overall. Article: Is Procter & Gamble’s Beauty Momentum Enough to Lift Growth?
• Positive Sentiment: Coverage highlights PG’s 70-year record of dividend increases and its quarterly payout of $1.0885 per share (about a 2.7% yield), which may appeal to income investors. These articles emphasize the dividend’s history rather than announcing a new increase. Article: Procter & Gamble’s Dividend Has Survived 26 Recessions
• Neutral Sentiment: The National Advertising Division found Unilever had support for the challenged moisturizing claims on Dove body wash in a challenge brought by P&G. This is a limited competitive setback, with no direct financial impact reported. Article: National Advertising Division Found Unilever’s Dove Deep Moisture Body Wash Claims Supported
• Negative Sentiment: CEO Juliana Mont Santos sold 5,370 shares and CFO Andre Schulten sold 30,677 shares at $169 on Nov. 5. Both retained substantial holdings, but the sales—and the reported reductions in their positions—could weigh on sentiment. SEC filing
• Negative Sentiment: A separate report says Zacks Research expects weaker earnings, a potential concern for investors; the provided coverage does not specify the forecast or its assumptions. Article: Zacks Research Predicts Weaker Earnings for Procter & Gamble

Procter & Gamble Profile